<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brain</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain</journal-id>
<journal-id journal-id-type="publisher-id">brainj</journal-id>
<journal-title-group>
<journal-title>Brain</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-8950</issn>
<issn pub-type="epub">1460-2156</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30649225</article-id>
<article-id pub-id-type="pmc">6933507</article-id>
<article-id pub-id-type="doi">10.1093/brain/awy323</article-id>
<article-id pub-id-type="publisher-id">awy323</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Update</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Banerjee</surname>
<given-names>Abhishek</given-names>
</name>
<xref ref-type="aff" rid="awy323-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miller</surname>
<given-names>Meghan T</given-names>
</name>
<xref ref-type="aff" rid="awy323-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Keji</given-names>
</name>
<xref ref-type="aff" rid="awy323-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sur</surname>
<given-names>Mriganka</given-names>
</name>
<xref ref-type="aff" rid="awy323-aff3">3</xref>
<xref ref-type="corresp" rid="awy323-cor2"></xref>
<!--<email>msur@mit.edu</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaufmann</surname>
<given-names>Walter E</given-names>
</name>
<xref ref-type="aff" rid="awy323-aff4">4</xref>
<xref ref-type="corresp" rid="awy323-cor1"></xref>
<!--<email>walter.e.kaufmann@emory.edu</email>-->
</contrib>
</contrib-group>
<aff id="awy323-aff1"><label>1</label>Laboratory of Neural Circuit Dynamics, Brain Research Institute, University of Zürich, Zürich, Switzerland</aff>
<aff id="awy323-aff2"><label>2</label>Roche Pharma Research and Early Development, Roche Innovation Center, F. Hoffman-La Roche, Basel, Switzerland</aff>
<aff id="awy323-aff3"><label>3</label>Department of Brain and Cognitive Sciences, Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge MA, USA</aff>
<aff id="awy323-aff4"><label>4</label>Department of Human Genetics, Emory University School of Medicine, Atlanta GA, USA</aff>
<author-notes>
<corresp id="awy323-cor1">Correspondence to: Dr Walter E. Kaufmann Department of Human Genetics Emory University School of Medicine Atlanta, GA 30322, USA E-mail: <email>walter.e.kaufmann@emory.edu</email></corresp>
<corresp id="awy323-cor2">Correspondence may also be addressed to: Dr Mriganka Sur Department of Brain and Cognitive Sciences Picower Institute for Learning and Memory Massachusetts Institute of Technology Cambridge, MA 02139, USA E-mail: <email>msur@mit.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2019-01-12" pub-type="epub">
<day>12</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>142</volume>
<issue>2</issue>
<fpage>239</fpage>
<lpage>248</lpage>
<history>
<date date-type="received">
<day>23</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>29</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="awy323.pdf"></self-uri>
<abstract abstract-type="teaser">
<p>Fifty years after the first publication on Rett syndrome, Banerjee <italic>et al.</italic> review the molecular, cellular and circuit neurobiology of the disorder. They summarize recent advances in therapeutic interventions explored in preclinical models, as well as lessons learnt from past clinical trials and how these might inform future therapeutic approaches.</p>
</abstract>
<abstract>
<title>Abstract</title>
<p>With the recent 50th anniversary of the first publication on Rett syndrome, and the almost 20 years since the first report on the link between Rett syndrome and <italic>MECP2</italic> mutations, it is important to reflect on the tremendous advances in our understanding and their implications for the diagnosis and treatment of this neurodevelopmental disorder. Rett syndrome features an interesting challenge for biologists and clinicians, as the disorder lies at the intersection of molecular mechanisms of epigenetic regulation and neurophysiological alterations in synapses and circuits that together contribute to severe pathophysiological endophenotypes. Genetic, clinical, and neurobiological evidences support the notion that Rett syndrome is primarily a synaptic disorder, and a disease model for both intellectual disability and autism spectrum disorder. This review examines major developments in both recent neurobiological and preclinical findings of Rett syndrome, and to what extent they are beginning to impact our understanding and management of the disorder. It also discusses potential applications of knowledge on synaptic plasticity abnormalities in Rett syndrome to its diagnosis and treatment.</p>
</abstract>
<kwd-group kwd-group-type="keywords">
<kwd>development</kwd>
<kwd>synapse</kwd>
<kwd>plasticity</kwd>
<kwd>autism</kwd>
<kwd>disorders</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">NIH</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>